Бифозил

Бифозил is an electrolyte solution designed for intravenous use, particularly during haemodialysis. It replenishes essential ions like magnesium, sodium, potassium, and chloride. This EU-manufactured product supports fluid and electrolyte balance in clinical settings. Ideal for patients requiring targeted ion supplementation.

Бифозил is used to restore electrolyte balance in patients undergoing haemodialysis or requiring intravenous ion supplementation. It helps address deficiencies in magnesium, sodium, potassium, and chloride ions, which are critical for cellular function and hydration. Commonly prescribed when oral intake is insufficient or impractical. Suitable for short-term correction of imbalances.

This solution works by directly infusing essential ions into the bloodstream, supporting normal muscle and nerve function. Users may experience improved hydration and reduced symptoms of electrolyte imbalance, such as fatigue or weakness. Effects are typically observed shortly after administration. Individual responses may vary based on underlying conditions.

Administer under medical supervision to monitor electrolyte levels and avoid overcorrection. Patients with kidney disorders or severe heart conditions should use with caution. Regular blood tests may be required to adjust dosing. Ensure compatibility with other intravenous therapies. Store in a controlled environment as per manufacturer guidelines.

Caution is advised when combining with medications affecting electrolyte balance, such as diuretics or ACE inhibitors. Concurrent use with calcium supplements may require monitoring for hypercalcemia. Always inform healthcare providers of all medications and supplements. Alcohol and certain foods may influence electrolyte absorption.